Invitation: On April 18-19, 2024, ≈©Haibu Pharmaceutical±&β‌ invites you to gather in ‍•↔★Chengdu for the [First F♠"uture XDC New Drug Conf★±erence].

Beijing Haibu Pharmaceutical Techn¶π≥&ology Co., Ltd. (referred to♣‍Ω" as "Haibu Pharmaceutic≈>↔al") was established in ↓ε€2005 and is a high-tech ent$ ∞erprise with "chemical ¶ drug research and d←<evelopment" as its core ca♦δpability. It has a rese" arch and development center in Beijing♦>, a pilot verification center for₹ → raw materials and formulations→£←, and a GMP industrial producti€×‍on base, mainly engaged in CRO serv™Ω☆∞ices for raw materials and f★↕ormulations, MAH joint licens₩αing, related applicat≈$•ions for raw materials, and commercia↕>≥₽l supply of pharmaceutical int↓γ∞≈ermediates.It has rich experience in the rese‌≥λ arch and production t  ≠ransfer, registration applicat£ ion, etc., of various dosage forms suc¶®h as chemical raw mater∏≥ials, oral solids, li∏±₽∑quid preparations, sterile injectio¥•>ns, and external preparations.₽∞↓ The R&D products cov↕↑er multiple therapeutic areas ≤₹including anti-tumor,"£ anti-depression, anti-epilepsy$​™, anti-anxiety, cardiovasculφ ar and cerebrovascular diseases, di☆×λgestive system disorde®Ωrs, respiratory system issues, etc.

Haibu Pharmaceutical has been≈φ♠÷ awarded the title of "Top 20 Chinese ✘¶Pharmaceutical R&D C™≈₽ompanies" for several consecutive yea✔ε₹♥rs and has been recogniz×≠∑δed as a "Specialized an' ​ d Innovative" enterprise in B↑'→eijing, a "National High-te ₩$↔ch Enterprise", a "Beijing Science and ≥₽<Technology Research Development Instit÷€ution", and a "Beijing Yizhua​&"¥ng Enterprise Innovation Ceδ€σ♥nter", among others.